HealthTech / Life Sciences Investors in Vancouver

Early-stage VC investing in Seed to pre-Series A technology startups, with a sector focus on software, SaaS, cloud services, marketplaces, mobile, big

Canada's Global Life Sciences Venture, sourcing promising therapeutics research from academic and biotech partners to create new companies of scale an

Connects Canadian businesses of all sizes and maturities, across all industries, to non-dilutive capital through debt financing against tax credits.

Direct-equity seed fund of the University of British Columbia investing 50,000 to 250,000 dollars into UBC-connected startups.

A 500 million dollar strategic investment fund of the Government of British Columbia; invests directly in BC-tied companies and as a limited partner i

Global deeptech and greentech companies reshaping legacy industries. Bridge between Canada and Asia-Pacific.

Growth-stage AI companies with proven product-market fit in Canada and UK.

Canadian health technology ventures increasing efficiencies and improving outcomes in healthcare.

Health tech and B2B technology at inflection point between commercialization and scale.

Invest at intersection of health care and innovation to accelerate technologies improving patient outcomes and health system sustainability.

Global venture capital company focused on equity financing of innovative biotechnology companies with breakthrough technology platforms.

Innovative private equity fund supporting entrepreneurs and executives fostering innovation in Canada's health and wellness industry.

Focus on most common age-related conditions: brain health, diabetes, cardiovascular, mobility, respiratory, musculoskeletal.

Founders of Canadian startups leading to a more sustainable, healthy, and equitable world.

Strategic investment arm in AgTech, Digital HealthTech, Connected Consumer, and Enterprise Platforms & IoT.

Two themes: AI & Analytics and Disruptive HardTech. Target companies with sustainable technological advantages.

Back mission-driven founders early in new areas. Focus on crypto, deep tech, and enterprise SaaS.

Flexible growth capital solutions (debt, convertible debt, structured equity) to mid-later stage technology companies. $10M-$50M.

Corporate venture arm of WELL Health Technologies investing in digital health, healthcare AI, and clinical software.